期刊
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 35, 期 3, 页码 865-872出版社
UNIV KARACHI
DOI: 10.36721/PJPS.2022.35.3.REG.865-872.1
关键词
Organotin(IV) dithiocarbamate; in situ insertion; antiproliferative; cytotoxicity; K562 cells
资金
- Fundamental Research Grant Scheme - Ministry of Higher Education Malaysia [FRGS/1/2018/STG01/UKM/02/20]
Four new organotin(IV) dithiocarbamate compounds were synthesized via in situ insertion method and characterized. These compounds showed cytotoxicity against K562 cells.
Four new organotin(IV) dithiocarbamate compounds with general formulae of PhnSn [S2CN(CH2CH2OCH2CH3)]4-n for compound 1 and 2; and PhnSn[S2CN(CH3)(CH2CH2C6H5)]4-n for compound 3 and 4 were successfully synthesized via in situ insertion method. These compounds namely, diphenyltin(IV)- [1] and triphenyltin(IV) N,N-bis(2-ethoxyethyl)dithiocarbamate [2], diphenyltin(IV)- [3] and triphenyltin(IV) N-methyl-Nphenethyldithiocarbamate [4] were each characterized with CHNS elemental analysis, FT-IR and NMR spectroscopies (1H, 13C and 119Sn). The compounds were then assessed for their cytotoxicity against K562 cells using 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazholium bromide (MTT) assay upon 24 h treatment. All compounds produced the essential IR absorption bands and displayed important NCS2 peak in 13C NMR spectroscopy. From the cytotoxicity studies using MTT assay, the compounds were shown to inhibit cell proliferation in K562 leukemic cells with IC50 values ranging from 1.48 to 4.52 ??M, and in the manners more cytotoxic compared to standard used imatinib.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据